We are live on
!
Find out more
CRB
Chad R. Baker Portfolio holdings
AUM
$620M
1-Year Est. Return
42.67%
This Fund
S&P 500
This Quarter
Est. Return
-10.74%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$232M
AUM Growth
-$42.5M
(-15%)
Cap. Flow
-$10.5M
Cap. Flow
% of AUM
-4.52%
Top 10 Holdings %
Top 10 Hldgs %
40.13%
Holding
56
New
1
Increased
–
Reduced
8
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$1.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.28M |
| 2 |
Norfolk Southern
NSC
|
+$1.84M |
| 3 |
J.M. Smucker
SJM
|
+$1.67M |
| 4 |
Gilead Sciences
GILD
|
+$1.2M |
| 5 |
Merck
MRK
|
+$1.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.04% |
| 2 | Industrials | 18.35% |
| 3 | Technology | 15.43% |
| 4 | Communication Services | 10.85% |
| 5 | Financials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Canadian National Railway
CNI
$77.3B
| $677K | 0.29% |
9,125
| – | – |
|
|
WIRE
52
DELISTED
Encore Wire Corp
WIRE
| $652K | 0.28% |
13,000
| – | – |
|
|
CDK
53
DELISTED
CDK Global, Inc.
CDK
| $519K | 0.22% |
10,833
| – | – |
|
54
Chevron
CVX
$379B
| – | – |
-2,472
| Closed | -$302K |
|
|
55
Gilead Sciences
GILD
$166B
| – | – |
-15,500
| Closed | -$1.2M |
|
|
ESRX
56
DELISTED
Express Scripts Holding Company
ESRX
| – | – |
-24,000
| Closed | -$2.28M |
|
Similar funds
RC
TTSTC
KFAS
RIS
AMG
BWP
MC
ACP
Chad R. Baker's Q4 2018 Portfolio in Review
As of Q4 2018, Chad R. Baker held 56 positions worth $232M, down 15% from $274M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Chad R. Baker withdrew a net $10.5M in Q4 2018, closing 3 positions and reducing 8 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $2.28M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Industrials and Technology.
Against the trend, Chad R. Baker opened a new position in Cigna worth $1.11M.
- Chad R. Baker's largest Q4 2018 buy was Cigna: 5,841 shares worth $1.11M.
- Chad R. Baker's biggest Q4 2018 reduction was Norfolk Southern, cutting an estimated $1.84M.
- Chad R. Baker fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $2.28M.
- Chad R. Baker's ten largest holdings make up 40% of its $232M portfolio in Q4 2018.
- Chad R. Baker opened 1 new position and closed 3 in Q4 2018.
- Chad R. Baker's portfolio value fell 15% quarter-over-quarter to $232M.
Based on Chad R. Baker's 13F filing for Q4 2018, filed 8 Feb 2019.